Back to Anglo Platinum  | Downloads  | Glossary  | Contact
	Home          Profile & mission          Key features          Chairman‘s statement          The board & executive          CEOs‘ review          Finance review       +   Market review       +   Operations review          Ore reserves & mineral resources review          Projects review       +   Company statistics            Financial statements Approval of the Annual Financial Statements Declaration by the Company Secretary Auditor‘s Report Directors‘ Report Remuneration Report Audit Committee Report Principal accounting policies Consolidated Income Statement Segmental Information Consolidated Balance Sheet Consolidated Cash Flow Statement Group Statement of Recognised Income and Expense United States Dollar Equivalent Consolidated Income Statement United States Dollar Equivalent Consolidated Balance Sheet United States Dollar Equivalent Consolidated Cash Flow Statement Notes to the Consolidated Financial Statements Annexures Appendix 1       +   Directorate & management       +   Shareholders‘ information	Financial statements  |  Notes to the Consolidated Financial Statements   print page   email page   PDF 639KB Explore Notes ---------------------------------------------------------------------------------------------- 1. Gross sales revenue ---------------------------------------------------------------------------------------------- 2. Exchange rates to the South African rand ---------------------------------------------------------------------------------------------- 3. Cash operating costs ---------------------------------------------------------------------------------------------- 4. Depreciation of operating assets ---------------------------------------------------------------------------------------------- 5. Other costs ---------------------------------------------------------------------------------------------- 6. Other net expenditure ---------------------------------------------------------------------------------------------- 7. Interest expensed and received ---------------------------------------------------------------------------------------------- 8. Profit before taxation ---------------------------------------------------------------------------------------------- 9. Taxation ---------------------------------------------------------------------------------------------- 10. Earnings per ordinary share ---------------------------------------------------------------------------------------------- 11. Reconciliation between net profit       and headline earnings ---------------------------------------------------------------------------------------------- 12. Ordinary and preference dividends ---------------------------------------------------------------------------------------------- 13. Property, plant and equipment ---------------------------------------------------------------------------------------------- 14. Capital work-in-progress ---------------------------------------------------------------------------------------------- 15. Exploration and evaluation ---------------------------------------------------------------------------------------------- 16. Investment in associates ---------------------------------------------------------------------------------------------- 17. Joint ventures ---------------------------------------------------------------------------------------------- 18. Investments held by environmental trusts ---------------------------------------------------------------------------------------------- 19. Other financial assets ---------------------------------------------------------------------------------------------- 20. Other non-current assets ---------------------------------------------------------------------------------------------- 21. Inventories ---------------------------------------------------------------------------------------------- 22. Accounts receivable ---------------------------------------------------------------------------------------------- 23. Other assets ---------------------------------------------------------------------------------------------- 24. Derivative financial assets ---------------------------------------------------------------------------------------------- 25. Cash and cash equivalents ---------------------------------------------------------------------------------------------- 26. Assets held for sale ---------------------------------------------------------------------------------------------- 27. Combined statement of movement in       shareholders’ funds and       movement in reserves ---------------------------------------------------------------------------------------------- 28. Share capital ---------------------------------------------------------------------------------------------- 29. Deferred taxation ---------------------------------------------------------------------------------------------- 30. Environmental obligations ---------------------------------------------------------------------------------------------- 31. Employee benefits ---------------------------------------------------------------------------------------------- 32. Obligations due under finance leases ---------------------------------------------------------------------------------------------- 33. Interest-bearing borrowings ---------------------------------------------------------------------------------------------- 34. Accounts payable ---------------------------------------------------------------------------------------------- 35. Other liabilities ---------------------------------------------------------------------------------------------- 36. Related party transactions ---------------------------------------------------------------------------------------------- 37. Reconciliation of profit before       taxation to cash from operations ---------------------------------------------------------------------------------------------- 38. Taxation paid ---------------------------------------------------------------------------------------------- 39. Purchase of property, plant and equipment ---------------------------------------------------------------------------------------------- 40. Commitments ---------------------------------------------------------------------------------------------- 41. Contingent liabilities ---------------------------------------------------------------------------------------------- 42. Change in accounting estimate ---------------------------------------------------------------------------------------------- 43. Financial instruments ---------------------------------------------------------------------------------------------- 44. Analysis of shareholders ---------------------------------------------------------------------------------------------- 45. Revision of conversion price applicable       to convertible preference shares ---------------------------------------------------------------------------------------------- 46. Comparative figures ---------------------------------------------------------------------------------------------- 47. Post-balance events ----------------------------------------------------------------------------------------------
		Notes to the Consolidated Financial Statements     2007 Rm    2006 Rm  31. Employee benefits Employees' service benefit obligations (non-current)       Provision for post-retirement medical aid benefits 24   33 Share-based payments provision 6   260 Total 505   578 Less: Transferred to liabilities associated with assets held for sale (Note 26) (25)   — Less: Transferred to current liabilities (474)   (318)     30   293 Aggregate earnings The aggregate earnings of employees including directors were: Salaries and wages and other benefits 7,423   5,847 Retirement benefit costs 586   438 Medical aid contributions 101   96 Share-based compensation (Note 5) 184   617 – Equity settled 57   89 – Cash settled (73)*   528 – Cash payments 200   —     8,294   6,998 * Includes an amount of R159 million relating to a correction of prior year overprovision   Termination benefits   Retrenchment costs 10   45 Directors’ emoluments Remuneration for executives – Fees —   — – Salaries, benefits, performance-related bonuses and other emoluments 51   33 Remuneration for non-executives   – Fees 3   3 Paid by holding company and subsidiaries 54   36 Paid by subsidiaries 51   33   Paid by holding company 3   3   Profit on share options exercised 73   30 Directors’ remuneration is fully disclosed in the Remuneration Committee Report, which is included in the Directors’ Report. Equity compensation benefits The Directors' Report sets out details of the Company's Share Option Scheme, and Annexure C provides details of share options issued and exercised during the year by participants as well as the disclosures required by IFRS 2 - Share-based Payments. The details pertaining to share options issued to and exercised by directors during the year are disclosed in the Remuneration Report.
		Page up
		Page  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65  66  67  68  69  70  71  72  73  74  75     Previous page  |  Financial statements 43/75
		Disclaimer